• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

L-45

CAS No. 2079885-05-3

L-45 ( PCAF BRD inhibitor L-45 )

产品货号. M13235 CAS No. 2079885-05-3

PCAF BRD inhibitor L-45 is a potent, selective, and cell-active PCAF bromodomain inhibitor with Ki of 47 nM in HTRF assays.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥2284 有现货
50MG ¥9477 有现货
100MG ¥14337 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    L-45
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    PCAF BRD inhibitor L-45 is a potent, selective, and cell-active PCAF bromodomain inhibitor with Ki of 47 nM in HTRF assays.
  • 产品描述
    PCAF BRD inhibitor L-45 is a potent, selective, and cell-active PCAF bromodomain inhibitor with Ki of 47 nM in HTRF assays, >4,500-fold selectivity over BRD4; disrupt PCAF-Brd histone H3.3 interaction in cells using a nanoBRET assay, shows high selectivity for PCAF and GCN5 bromodomain (Kd=600 nM); shows no observable cytotoxicity in PBMCs, good cell-permeability, and metabolic stability in human and mouse liver microsomes.
  • 同义词
    PCAF BRD inhibitor L-45
  • 通路
    Chromatin/Epigenetic
  • 靶点
    Bromodomain
  • 受体
    Bromodomain
  • 研究领域
    Cancer
  • 适应症
    ——

化学信息

  • CAS Number
    2079885-05-3
  • 分子量
    360.47
  • 分子式
    C21H24N6
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    C[C@H](NC(C1=C2C=CC=C1)=NN3C2=NN=C3C)[C@H](C4=CC=CC=C4)N(C)C
  • 化学全称
    (1S,2S)-N1,N1-dimethyl-N2-(3-methyl-[1,2,4]triazolo[3,4-a]phthalazin-6-yl)-1-phenylpropane-1,2-diamine

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Moustakim M, et al. Angew Chem Int Ed Engl. 2017 Jan 16;56(3):827-831.
产品手册
关联产品
  • GSK1324726A

    A potent and selective inhibitor of BET bromodomain with IC50 of 41 nM/31 nM/22 nM for BRD2/BRD3/BRD4 respectively.

  • CeMMEC2

    CeMMEC2 is a novel potent BRD4 inhibitor with IC50 of 0.9 uM.

  • BMS 986158

    BMS-986158 (BMS986158) is a potent and selective BET inhibitor.